Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions.
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
28 May 2024
28 May 2024
Historique:
received:
27
03
2024
accepted:
22
05
2024
medline:
30
5
2024
pubmed:
30
5
2024
entrez:
30
5
2024
Statut:
epublish
Résumé
Diabetes mellitus, a complex metabolic disorder, presents a growing global health challenge. In 2021, there were 529 million diabetics worldwide. At the super-regional level, Oceania, the Middle East, and North Africa had the highest age-standardized rates. The majority of cases of diabetes in 2021 (>90.0%) were type 2 diabetes, which is largely indicative of the prevalence of diabetes in general, particularly in older adults (K. L. Ong,
Identifiants
pubmed: 38813124
doi: 10.1039/d4ra02349h
pii: d4ra02349h
pmc: PMC11135279
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
17448-17460Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
All authors declare that they have no conflicts of interest that could inappropriately influence this manuscript.